Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway.
about
The 26S proteasome is a multifaceted target for anti-cancer therapiesA phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignanciesPDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation.Distinct antifibrogenic effects of erlotinib, sunitinib and sorafenib on rat pancreatic stellate cells.Matrine induces apoptosis in human acute myeloid leukemia cells via the mitochondrial pathway and Akt inactivationSynergistic Antivascular and Antitumor Efficacy with Combined Cediranib and SC6889 in Intracranial Mouse Glioma.Synergistic suppression of the PI3K inhibitor CAL-101 with bortezomib on mantle cell lymphoma growthThe Bruton tyrosine kinase (BTK) inhibitor PCI-32765 synergistically increases proteasome inhibitor activity in diffuse large-B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) cells sensitive or resistant to bortezomib.Metastatic melanoma - a review of current and future drugsThe antiproliferative effect of C2-ceramide on lung cancer cells through apoptosis by inhibiting Akt and NFκB.Tetraspanin 8 is a novel regulator of ILK-driven β1 integrin adhesion and signaling in invasive melanoma cells.Towards combinatorial targeted therapy in melanoma: from pre-clinical evidence to clinical application (review).Matrine inhibits the growth and induces apoptosis of osteosarcoma cells in vitro by inactivating the Akt pathway.Functional exploration of colorectal cancer genomes using Drosophila.Blockade of NFκB activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells.Functional expression of voltage-gated calcium channels in human melanoma.Synthesis of piperazine-based thiazolidinones as VEGFR2 tyrosine kinase inhibitors inducing apoptosis.Synthesis and antiproliferative evaluation of 9-methoxy-6-(piperazin-1-yl)-11H-indeno[1,2-c]quinoline-11-one derivatives. Part 4
P2860
Q26795764-53E5D72C-369D-46B0-A8F0-752AD8A4C0BAQ33405318-97CAAB34-45F0-4027-B6CA-DE7B32177762Q33688428-8D7812D3-77C9-4C52-8C02-4D7EFB81F683Q33801399-7C35F458-2D54-4E13-95FA-BBB08770E186Q34442297-4A905655-DC94-4EB4-9931-D0845BF507C4Q35863135-55BAAE15-213F-4B9D-9C4B-A86AA2BE84D0Q36445743-9685D9DA-AEAD-498F-80E1-24CC4C8288ADQ37084564-40477EE9-B7AE-4109-8EEB-F7E2ABB6431CQ37450733-9D9EE4C8-3E9A-422A-B322-A769ADF97F56Q37484846-1CB68321-A3AE-412D-A706-B7B05F6C719BQ37725588-C0B3236B-19D1-42BC-A1E9-2354297A06E4Q38219616-400C9737-B54C-412E-9A7E-2C0843595CD3Q38942657-E87F29FC-DB2B-4F6A-B9A9-11624DC4B3F9Q39145987-E6CC668B-B49F-4B04-BE32-50F56B1F8434Q39310876-ADAD7D77-2E9D-44F2-B708-604949C83125Q39409759-58E2CFF4-6693-47A9-8EDF-85D5FAE9923DQ47660354-7DE9037A-D79D-471F-AE2C-CFE0AFC532BAQ57236117-DFC1A358-BFBB-4BDB-9F7D-99CA2EEA02D6
P2860
Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Inhibition of activated recept ...... zomib by blocking Akt pathway.
@en
Inhibition of activated recept ...... zomib by blocking Akt pathway.
@nl
type
label
Inhibition of activated recept ...... zomib by blocking Akt pathway.
@en
Inhibition of activated recept ...... zomib by blocking Akt pathway.
@nl
prefLabel
Inhibition of activated recept ...... zomib by blocking Akt pathway.
@en
Inhibition of activated recept ...... zomib by blocking Akt pathway.
@nl
P2093
P2860
P50
P356
P1476
Inhibition of activated recept ...... ezomib by blocking Akt pathway
@en
P2093
Andree Yeramian
Antonio Llombart-Cussac
Josep M Casanova
Leandre Abal
Ramón Egido
Ramón Vilella
Sara Moreno
Xavier Dolcet
Xavier Matias-Guiu
P2860
P304
P356
10.1002/IJC.26096
P577
2011-06-18T00:00:00Z